Clinical Trial Update: Study of Ketamine for Depression in Cancer Patients Receiving Palliative Care [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ketamine for depression in cancer patients receiving palliative care has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Depression, Cancer | Phase 2 | Status: COMPLETED